Skip to menu Skip to content Skip to footer

2002

Conference Publication

The effect of obesity on renal transplant outcomes

Johnson, D. W., Isbel, N., Kay, T. D., Hawley, C., Campbell, S. B. and Nicol, D. L. (2002). The effect of obesity on renal transplant outcomes. Australian and New Zealand Society of Nephrology 37th Annual Scientific Meeting, Darwin, N. T., 5th - 7th September, 2001. Carlton, Victoria: Blackwell Science. doi: 10.1046/j.1440-1797.2002.00007-1-39.x

The effect of obesity on renal transplant outcomes

2002

Conference Publication

A cross-over trial comparing intravenous (IV) and oral iron supplementation in erythropoietin (EPO) - treated peritoneal dialysis (PD) patients

Johnson, David W., Herzig, Karen A., Campbell, Scott Bryan, Hawley, Carmel M. and Isbel, Nicole M. (2002). A cross-over trial comparing intravenous (IV) and oral iron supplementation in erythropoietin (EPO) - treated peritoneal dialysis (PD) patients. 37th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Darwin, 5th - 7th September, 2001. Carlton, Victoria: Blackwell Science. doi: 10.1046/j.1440-1797.2002.00007-1-63.x

A cross-over trial comparing intravenous (IV) and oral iron supplementation in erythropoietin (EPO) - treated peritoneal dialysis (PD) patients

2002

Conference Publication

Macrophage-colony stimulating factor (M-CSF): A risk factor for atherosclerosis in uraemia?

Isbel, N. M., Fathi, R., Kennedy, R., Haluska, B., Short, L., Hawley, C. M., Campbell, S. B., Marwick, T. and Johnson, D. W. (2002). Macrophage-colony stimulating factor (M-CSF): A risk factor for atherosclerosis in uraemia?. 37th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Darwin, N.T., 5th - 7th September, 2001. Carlton, Victoria: Blackwell Science. doi: 10.1046/j.1440-1797.2002.00007-1-140.x

Macrophage-colony stimulating factor (M-CSF): A risk factor for atherosclerosis in uraemia?

2002

Conference Publication

Is mycophenolate mofetil (MMF) less safe than azathioprine in older renal transplant patients?

Johnson, D. W., Nicol, D., Campbell, S. B., Petrie, J., Hawley, C. M. and Isbel, N. M. (2002). Is mycophenolate mofetil (MMF) less safe than azathioprine in older renal transplant patients?. Australian and New Zealand Society of Nephrology 37th Annual Scientific Meeting, Darwin, N. T., 5th - 7th September, 2001. Carlton, Victoria: Blackwell Science. doi: 10.1046/j.1440-1797.2002.00007-1-89.x

Is mycophenolate mofetil (MMF) less safe than azathioprine in older renal transplant patients?

2001

Journal Article

A prospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in peritoneal dialysis patients

Johnson, David W., Herzig, Karen A., Gissane, Ruth, Campbell, Scott B., Hawley, Carmel M. and Isbel, Nicole M. (2001). A prospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in peritoneal dialysis patients. Nephrology Dialysis Transplantation, 16 (9), 1879-1884. doi: 10.1093/ndt/16.9.1879

A prospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in peritoneal dialysis patients

2001

Journal Article

Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?

Herzig, K. A., Purdie, D. M., Chang, W., Brown, A. M., Hawley, C. M., Campbell, S. B., Sturtevant, J. M., Isbel, N. M., Nicol, D. L. and Johnson, D. W. (2001). Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?. Journal of the American Society of Nephrology, 12 (4), 814-821.

Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?

2001

Journal Article

Does renal failure cause an atherosclerotic milieu in patients with end-stage renal disease?

Kennedy, Robert, Case, Colin, Fathi, Robert, Johnson, David, Isbel, Nicole and Marwick, Thomas H. (2001). Does renal failure cause an atherosclerotic milieu in patients with end-stage renal disease?. American Journal of Medicine, 110 (3), 198-204. doi: 10.1016/S0002-9343(00)00695-1

Does renal failure cause an atherosclerotic milieu in patients with end-stage renal disease?

2001

Conference Publication

Oral versus intravenous iron supplementation in peritoneal dialysis patients

Johnson, D. W., Herzig, K. A., Gissane, R., Campbell, S. B., Hawley, C. M. and Isbel, N. M. (2001). Oral versus intravenous iron supplementation in peritoneal dialysis patients. 9th Congress of the International Society of Peritoneal Dialysis, Montreal, QC, Canada, 26-29 June 2001. Thousand Oaks, CA, United States: Sage Publications. doi: 10.1177/089686080102103S41

Oral versus intravenous iron supplementation in peritoneal dialysis patients

2001

Conference Publication

With the best of intentions: Is it possible to meet the CARI guidelines?

Isbel, N., Bailey, R., Beal, B., Hawley, C. M., Campbell, S. B., Petrie, J. J., Burke, J., Bofinger, A. M., Marwick, T. H. and Johnson, D. W. (2001). With the best of intentions: Is it possible to meet the CARI guidelines?. Australian and New Zealand Society of Nephrology 37th Annual Scientific Meeting, Darwin, N.T., 5-7 September, 2001. Carlton, Victoria: Blackwell Science. doi: 10.1046/j.1440-1797.2002.00007-1-90.x

With the best of intentions: Is it possible to meet the CARI guidelines?

2001

Journal Article

Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantation

Jonsson, Julie R., Hong, Cui, Purdie, David M., Hawley, Carmel, Isbel, Nicky, Butler, Maree, Balderson, Glenda A., Clouston, Andrew D., Pandeya, Nirmala, Stuart, Katherine, Edwards-Smith, Catherine, Crawford, Darrel H., Fawcett, Jonathon and Powell, Elizabeth E. (2001). Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantation. Liver Transplantation, 7 (3), 255-263. doi: 10.1053/jlts.2001.22450

Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantation

2000

Conference Publication

Is C-reactive protein (CRP) a useful predictor of patient outcome in peritoneal dialysis

Herzig, K., Purdie, D., Chang, W., Brown, A., Hawley, C. M., Campbell, S. B., Rigby, R., Isbel, N., Nicol, D. L. and Johnson, D. W. (2000). Is C-reactive protein (CRP) a useful predictor of patient outcome in peritoneal dialysis. MELBOURNE, 15-17 MARCH 2000.

Is C-reactive protein (CRP) a useful predictor of patient outcome in peritoneal dialysis

2000

Conference Publication

A single centre experience of post-renal transplant lymphoproligerative disorder (PTLD)

Herzig, K., Juffs, H., Brown, A. M., Gill, D., Hawley, C. M., Cobcroft, R., Petrie, J. J., Marlton, P., Rigby, R., Thomson, D., Campbell, S. B., Isbel, N., Nicol, D. L. and Johnson, D. W. (2000). A single centre experience of post-renal transplant lymphoproligerative disorder (PTLD). Melbourne, 15-17 March 2000.

A single centre experience of post-renal transplant lymphoproligerative disorder (PTLD)

2000

Journal Article

Peritoneal homocysteine clearance is inefficient in peritoneal dialysis patients

Johnson, David W., Kay, Troy D., Vesey, David A., Isbel, Nicole, Campbell, Scott B. and Hawley, Carmel M. (2000). Peritoneal homocysteine clearance is inefficient in peritoneal dialysis patients. Peritoneal Dialysis International, 20 (6), 766-771.

Peritoneal homocysteine clearance is inefficient in peritoneal dialysis patients

2000

Conference Publication

The role of cytokine gene polymorphisms in renal impairment after liver transplantation

Jonsson, Julie R., Hong, Cui, Isbel, Nicky, Hawley, Carmel, Butler, Maree, Purdie, David M., Pandeya, Nirmala, Balderson, Glenda A., Clouston, Andrew D., Edwards-Smith, C., Lynch, Stephen V. and Powell, Elizabeth E. (2000). The role of cytokine gene polymorphisms in renal impairment after liver transplantation. American Association for Study of Liver Disease, Dallas, U.S.A., 27-31 October, 2000. Hoboken, NJ: Wiley Interscience.

The role of cytokine gene polymorphisms in renal impairment after liver transplantation

2000

Conference Publication

Does renal failure cause endothelial dysfunction and atherosclerosis?

Kennedy, R., Case, C., Johnson, D. W., Isbel, N. and Marwick, T. H. (2000). Does renal failure cause endothelial dysfunction and atherosclerosis?. 49th Annual Scientific Session, Anaheim, California, USA, 12-15 March 2000. Elssevier Science:

Does renal failure cause endothelial dysfunction and atherosclerosis?